References
- CohenMLChanging patterns of infectious diseaseNature2000406679776276710963605
- YoneyamaHKatsumataRAntibiotic resistance in bacteria and its future for novel antibiotic developmentBiosci Biotechnol Biochem20067051060107516717405
- FauciASInfectious diseases: considerations for the 21st centuryClin Infect Dis200132567568511229834
- NathanCAntibiotics at the crossroadsNature2004431701189990215496893
- ProjanSJNew (and not so new) antibacterial targets – from where and when will the novel drugs come?Curr Opin Pharmacol20022551352212324252
- LeebMAntibiotics: a shot in the armNature2004431701189289315496888
- ChambersHFMethicillin resistance in staphylococci: molecular and biochemical basis and clinical implicationsClin Microbiol Rev19971047817919336672
- FairRJTorYAntibiotics and bacterial resistance in the 21st centuryPerspect Medicin Chem20146256425232278
- TassiosPTGennimataVSpaliara-KalogeropoulouLMultiresistant Pseudomonas aeruginosa serogroup O:11 outbreak in an intensive care unitClin Microbiol Infect19973662162811864203
- Al-MarzoqiAAl-TaeeZPseudomonas aeruginosa: Antibiotic resistance pattern to different isolates in Al-Hillah city, IraqJ Natl Sci Res2013336974
- LockhartSRAbramsonMABeekmannSEAntimicrobial resistance among Gram-negative bacilli causing infections in intensive care unit patients in the United States between 1993 and 2004J Clin Microbiol200745103352335917715376
- MaragakisLLPerlTMAcinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment optionsClin Infect Dis20084681254126318444865
- FournierBArletGLagrangePHPhilipponAKlebsiella oxytoca: resistance to aztreonam by overproduction of the chromosomally encoded beta-lactamaseFEMS Microbiol Lett1994116131368132152
- BabiniGSLivermoreDMAntimicrobial resistance amongst Klebsiella spp. collected from intensive care units in Southern and Western Europe in 1997–1998J Antimicrob Chemother200045218318910660500
- YangYJLivermoreDMChromosomal beta-lactamase expression and resistance to beta-lactam antibiotics in Proteus vulgaris and Morganella morganiiAntimicrob Agents Chemother1988329138513913058021
- LunguBO’BryanCAMuthaiyanAListeria monocytogenes: antibiotic resistance in food productionFoodborne Pathog Dis20118556957821166580
- KimHRyuJHBeuchatLRAttachment of and biofilm formation by Enterobacter sakazakii on stainless steel and enteral feeding tubesAppl Environ Microbiol20067295846585616957203
- HøibyNBjarnsholtTGivskovMMolinSCiofuOAntibiotic resistance of bacterial biofilmsInt J Antimicrob Agents201035432233220149602
- TsengBSZhangWHarrisonJJThe extracellular matrix protects Pseudomonas aeruginosa biofilms by limiting the penetration of tobramycinEnviron Microbiol201315102865287823751003
- CaoBChristophersenLThomsenKAntibiotic penetration and bacterial killing in a Pseudomonas aeruginosa biofilm modelJ Antimicrob Chemother20157072057206325786481
- MartinoPDFursyRBretLSundararajuBPhillipsRSIndole can act as an extracellular signal to regulate biofilm formation of Escherichia coli and other indole-producing bacteriaCan J Microbiol200349744344914569285
- TangXFlintSHBennettRJBrooksJDMortonRHBiofilm growth of individual and dual strains of Klebsiella oxytoca from the dairy industry on ultrafiltration membranesJ Ind Microbiol Biotechnol200936121491149719760228
- Mingeot-LeclercqMPGlupczynskiYTulkensPMAminoglycosides: activity and resistanceAntimicrob Agents Chemother199943472773710103173
- DozzoPMoserHENew aminoglycoside antibioticsExpert Opin Ther Pat201020101321134120670208
- SchroederMBrooksBDBrooksAEThe Complex Relationship between Virulence and Antibiotic ResistanceGenes (Basel)201781E3928106797
- MoritaYTomidaJKawamuraYResponses of Pseudomonas aeruginosa to antimicrobialsFront Microbiol2014442243024409175
- KohanskiMADwyerDJCollinsJJHow antibiotics kill bacteria: from targets to networksNat Rev Microbiol20108642343520440275
- BrileneTSoeorgHKiisMIn vitro synergy of oxacillin and gentamicin against coagulase-negative staphylococci from blood cultures of neonates with late-onset sepsisAPMIS2013121985986423294372
- AldahmashBAEl-NagarDMIbrahimKEReno-protective effects of propolis on gentamicin-induced acute renal toxicity in swiss albino miceNefrologia2016366643652 Spanish27575929
- AlhajlanMAlhaririMOmriAEfficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factorsAntimicrob Agents Chemother20135762694270423545534
- MozafariMFlanaganJMatia-MerinoLRecent trends in the lipid-based nanoencapsulation of antioxidants and their role in foodsJ Sci Food Agr2006861320382045
- AlhaririMOmriAEfficacy of liposomal bismuth-ethanedithiol-loaded tobramycin after intratracheal administration in rats with pulmonary Pseudomonas aeruginosa infectionAntimicrob Agents Chemother201357156957823147741
- AlhaririMAzghaniAOmriALiposomal antibiotics for the treatment of infectious diseasesExpert Opin Drug Deliv201310111515153223886421
- MarierJFBrazierJLLavigneJDucharmeMPLiposomal tobramycin against pulmonary infections of Pseudomonas aeruginosa: a pharmacokinetic and efficacy study following single and multiple intratracheal administrations in ratsJ Antimicrob Chemother200352224725212837733
- JustoORMoraesAMIncorporation of antibiotics in liposomes designed for tuberculosis therapy by inhalationDrug Deliv200310320120712944141
- MugabeCAzghaniAOOmriAPreparation and characterization of dehydration-rehydration vesicles loaded with aminoglycoside and macrolide antibioticsInt J Pharm2006307224425016289986
- HalwaniMYebioBSuntresZEAlipourMAzghaniAOOmriACo-encapsulation of gallium with gentamicin in liposomes enhances antimicrobial activity of gentamicin against Pseudomonas aeruginosaJ Antimicrob Chemother20086261291129718931388
- HalwaniMMugabeCAzghaniAOLafrenieRMKumarAOmriABactericidal efficacy of liposomal aminoglycosides against Burkholderia cenocepaciaJ Antimicrob Chemother200760476076917673475
- HalwaniMHebertSSuntresZELafrenieRMAzghaniAOOmriABismuth-thiol incorporation enhances biological activities of liposomal tobramycin against bacterial biofilm and quorum sensing molecules production by Pseudomonas aeruginosaInt J Pharm20093731–214114619429299
- MugabeCHalwaniMAzghaniAOLafrenieRMOmriAMechanism of enhanced activity of liposome-entrapped aminoglycosides against resistant strains of Pseudomonas aeruginosaAntimicrob Agents Chemother20065062016202216723560
- European Committee for Antimicrobial Susceptibility Testing of the European Society of Clinical M, Infectious DDetermination of minimum inhibitory concentrations (MICs) of antibacterial agents by broth dilutionClin Microbiol Infect200398ixxv
- RukholmGMugabeCAzghaniAOOmriAAntibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill studyInt J Antimicrob Agents200627324725216472992
- NaparstekLCarmeliYNavon-VeneziaSBaninEBiofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniaeJ Antimicrob Chemother20146941027103424408988
- HasaninAOmriALiposomal N-acetylcysteine modulates the pathogenesis of P. aeruginosa isolated from the lungs of cystic fibrosis patientJ Nanomed Nanotechnol201454219230
- Villasmil-SánchezSRabascoAMGonzález-RodriguezMLThermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomesColloids Surf B Biointerfaces2013105142323352939
- LiYHuangLTangCZhangEDingLYangLPreparation and characterisation of the colistin-entrapped liposome driven by electrostatic interaction for intravenous administrationJ Microencapsul201633542743727388548
- ChouguleMPadhiBMisraANano-liposomal dry powder inhaler of tacrolimus: preparation, characterization, and pulmonary pharmacokineticsInt J Nanomedicine20072467568818203434
- HosnyKMCiprofloxacin as ocular liposomal hydrogelAAPS Pharm-SciTech2010111241246
- SolletiVSAlhaririMHalwaniMOmriAAntimicrobial properties of liposomal azithromycin for Pseudomonas infections in cystic fibrosis patientsJ Antimicrob Chemother201570378479625416744
- AndersonMOmriAThe effect of different lipid components on the in vitro stability and release kinetics of liposome formulationsDrug Deliv2004111333915168789
- BontéFJulianoRLInteractions of liposomes with serum proteinsChem Phys Lipids1986402–43593723742678
- SimõesSMoreiraJNFonsecaCDüzgüneşNde LimaMCOn the formulation of pH-sensitive liposomes with long circulation timesAdv Drug Deliv Rev200456794796515066754
- Hernández-CasellesTVillalainJGómez-FernándezJCInfluence of liposome charge and composition on their interaction with human blood serum proteinsMol Cell Biochem199312021191268487752
- VitasAIDiazRGamazoCProtective effect of liposomal gentamicin against systemic acute murine brucellosisChemotherapy19974332042109142462
- BeaulacCSachetelliSLagaceJIn-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteriaJ Antimicrob Chemother199841135419511035
- Drulis-KawaZGubernatorJDorotkiewicz-JachADoroszkiewiczWKozubekAA comparison of the in vitro antimicrobial activity of liposomes containing meropenem and gentamicinCell Mol Biol Lett200611336037516847556
- MessiaenASForierKNelisHBraeckmansKCoenyeTTransport of nanoparticles and tobramycin-loaded liposomes in Burkholderia cepacia complex biofilmsPLoS One2013811e7922024244452